Literature DB >> 23988345

CCK response in bulimia nervosa and following remission.

Sandra L Hannon-Engel1, Evgeniy E Filin, Barbara E Wolfe.   

Abstract

The core defining features of bulimia nervosa (BN) are repeated binge eating episodes and inappropriate compensatory (e.g., purging) behavior. Previous studies suggest an abnormal post-prandial response in the satiety-signaling peptide cholecystokinin (CCK) in persons with BN. It is unknown whether this altered response persists following remission or if it may be a potential target for the development of clinical treatment strategies. To examine the nature of this altered response, this study assessed whether CCK normalizes following remission from BN (RBN). This study prospectively evaluated the plasma CCK response and corresponding eating behavior-related ratings (e.g., satiety, fullness, hunger, urge to binge and vomit) in individuals with BN-purging subtype (n=10), RBN-purging subtype (n=14), and healthy controls (CON, n=13) at baseline, +15, +30, and +60 min following the ingestion of a standardized liquid test meal. Subject groups did not significantly differ in CCK response to the test meal. A significant relationship between CCK response and satiety ratings was observed in the RBN group (r=.59, p<.05 two-tailed). A new and unanticipated finding in the BN group was a significant relationship between CCK response and ratings of "urge to vomit" (r=.86, p<.01, two-tailed). Unlike previous investigations, CCK response did not differ in BN and CON groups. Thus the role of symptom severity remains an area of further investigation. Additionally, findings suggest that in this sample, CCK functioning following remission from BN-purging subtype is not different from controls. It remains unknown whether or not CCK functioning may be a protective or liability factor in the stabilization and recovery process. Replication studies utilizing a larger sample size are needed to further elucidate the role of CCK in recovery from BN and its potential target of related novel treatment strategies.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Binge eating; Bulimia nervosa; CCK; Eating behavior; Eating disorder; Purging; Satiety

Mesh:

Substances:

Year:  2013        PMID: 23988345      PMCID: PMC4395462          DOI: 10.1016/j.physbeh.2013.08.014

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  22 in total

1.  Hunger and satiety in anorexia and bulimia nervosa.

Authors:  K A Halmi; S Sunday; A Puglisi; P Marchi
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

2.  Comparison of the effects of amino acid mixture and placebo on plasma tryptophan to large neutral amino acid ratio.

Authors:  B E Wolfe; E D Metzger; D C Jimerson
Journal:  Life Sci       Date:  1995-03-17       Impact factor: 5.037

3.  Gastric emptying and symptoms of bulimia nervosa: effect of a prokinetic agent.

Authors:  Michael J Devlin; Harry R Kissileff; Ellen J Zimmerli; Francine Samuels; Benny E Chen; Amanda J Brown; Allan Geliebter; B Timothy Walsh
Journal:  Physiol Behav       Date:  2012-02-14

Review 4.  The (mis)measurement of restraint: an analysis of conceptual and psychometric issues.

Authors:  T F Heatherton; C P Herman; J Polivy; G A King; S T McGree
Journal:  J Abnorm Psychol       Date:  1988-02

5.  Sensitivity and accuracy of the visual analogue scale: a psycho-physical classroom experiment.

Authors:  C Maxwell
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

6.  Relationship of satiety to postprandial glycaemic, insulin and cholecystokinin responses.

Authors:  S Holt; J Brand; C Soveny; J Hansky
Journal:  Appetite       Date:  1992-04       Impact factor: 3.868

7.  Serotonin function following remission from bulimia nervosa.

Authors:  B E Wolfe; E D Metzger; J M Levine; D M Finkelstein; T B Cooper; D C Jimerson
Journal:  Neuropsychopharmacology       Date:  2000-03       Impact factor: 7.853

8.  Impaired cholecystokinin secretion in bulimia nervosa.

Authors:  T D Geracioti; R A Liddle
Journal:  N Engl J Med       Date:  1988-09-15       Impact factor: 91.245

9.  Satiety and cholecystokinin.

Authors:  K M Pirke; M B Kellner; E Friess; J C Krieg; M M Fichter
Journal:  Int J Eat Disord       Date:  1994-01       Impact factor: 4.861

10.  Validity of the Eating Disorder Examination Questionnaire (EDE-Q) in screening for eating disorders in community samples.

Authors:  J M Mond; P J Hay; B Rodgers; C Owen; P J V Beumont
Journal:  Behav Res Ther       Date:  2004-05
View more
  3 in total

Review 1.  Emerging Treatments in Eating Disorders.

Authors:  Michael Lutter
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

Review 2.  Hormonal Factors and Disturbances in Eating Disorders.

Authors:  Kristen M Culbert; Sarah E Racine; Kelly L Klump
Journal:  Curr Psychiatry Rep       Date:  2016-07       Impact factor: 5.285

Review 3.  Current Aspects of the Role of Autoantibodies Directed Against Appetite-Regulating Hormones and the Gut Microbiome in Eating Disorders.

Authors:  Kvido Smitka; Petra Prochazkova; Radka Roubalova; Jiri Dvorak; Hana Papezova; Martin Hill; Jaroslav Pokorny; Otomar Kittnar; Martin Bilej; Helena Tlaskalova-Hogenova
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-19       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.